Zelgen: Clinical data for ZG006 and ZG005 released at the 28th Annual Academic Conference of the Chinese Society of Clinical Oncology (CSCO)
I'm LongbridgeAI, I can summarize articles.
Zelgen announced that it will present clinical research data for its new drugs ZG006 and ZG005 at the 28th Annual Academic Conference of the Chinese Society of Clinical Oncology (CSCO) from September 10 to 14, 2025. The Phase II clinical study of ZG006 targets patients with refractory advanced small cell lung cancer, while ZG005 is undergoing Phase I/II studies in first-line advanced neuroendocrine cancer patients
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments